[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-abdominal-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-abdominal-pain":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100635711","gastric-electrical-stimulation-for-abdominal-pain-in-patients-with-gastroparesis-100635711",false,"NCT07556237","Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis","HEAL","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Diagnosed gastroparesis.\n* Implanted Enterra™ device for at least 8 weeks prior to enrollment.\n* Chronic daily abdominal pain of gastric origin lasting more than 2 months.\n* Average pain score ≥4 on a 0-10 scale.\n* Ability to provide informed consent.\n\nExclusion Criteria:\n\n* Daily opioid use.\n* Pregnancy or breastfeeding.\n* Abdominal pain not attributed to gastric\u002Fvisceral origin.\n* Severe constipation or uncontrolled diabetes (HbA1c \\>10).\n* Other medical conditions that would interfere with study participation.","ALL","18 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"NA","Gastroparesis is a disorder characterized by delayed gastric emptying and symptoms including nausea, vomiting, and abdominal pain. Gastric electrical stimulation (GES) using the implanted Enterra™ neurostimulator is FDA-approved to treat nausea and vomiting but its impact on abdominal pain has not been well studied. This study evaluates whether alternative programming parameters of the Enterra™ device can reduce abdominal pain in patients with gastroparesis. Participants with an existing Enterra™ device will be randomized to one of three stimulation settings and followed for assessment of pain, gastrointestinal symptoms, quality of life, and medication use.",[26,27],"Gastroparesis","Chronic Abdominal Pain",[29,30,31,32,33],"Gastric Electrical Stimulation","Enterra","Visceral pain","Gastroparesis pain","Neuromodulation","NOT_YET_RECRUITING","2026-04-28",{"date":37,"type":38},"2026-05-04","ACTUAL",{"date":40,"type":20},"2026-07",{"date":42,"type":20},"2030-07",{"name":44,"class":45},"University of Louisville","OTHER"]